ACME United Corporation — Q1 2024 Form 10-Q Summary
Business Context and Reporting Period
This unaudited Form 10-Q covers the three months ended March 31, 2024. Acme United sells first aid and medical products and cutting and sharpening products through its United States, Canada, and Europe segments. Results are seasonally stronger in the second and third quarters because of the Westcott back-to-school market.
The comparison period is the three months ended March 31, 2023. The prior-year comparison is affected by the November 2023 divestiture of the Camillus Cutlery and Cuda business lines.
Key Financial Metrics
| Metric | Q1 2024 | Q1 2023 | Change |
|---|---|---|---|
| Net sales | $45.0 million | $45.8 million | Down 1.9% |
| Gross profit | $17.4 million | $16.3 million | Up 6.8% |
| Gross margin | 38.7% | 35.5% | Up 320 basis points |
| SG&A expense | $14.8 million | $14.1 million | Up $0.7 million |
| Operating income | $2.6 million | $2.2 million | Up 16.9% |
| Operating margin | 5.7% | 4.8% | Improved |
| Net income | $1.6 million | $1.0 million | Up 65.3% |
| Diluted EPS | $0.39 | $0.28 | Up $0.11 |
| Net cash used in operating activities | $(10.2) million | $7.7 million provided | Material deterioration |
Net margin was approximately 3.6% in Q1 2024 versus 2.2% in Q1 2023. The effective income tax rate was 24% in both periods. Dividends declared increased to $0.15 per share from $0.14.
Revenue and Segment Performance
- Consolidated sales declined 1% as reported, but increased 1% excluding the divested Camillus and Cuda product lines.
- United States sales declined 2% as reported and increased 1% excluding the divestiture. United States operating income increased $0.6 million to $2.3 million.
- Canada sales declined 7% in U.S. dollars, or 6% in local currency, while Canadian operating income declined $0.2 million to $39,000.
- Europe sales increased 5% in U.S. dollars, or 4% in local currency. European operating income declined slightly to $180,000.
- First Aid and Medical sales were $27.1 million, compared with $27.0 million in the prior-year quarter. Cutting and Sharpening sales were $17.9 million, compared with $18.8 million.
Cash Flow, Liquidity, Debt, and Balance Sheet
- Cash, cash equivalents, and restricted cash totaled $3.2 million at March 31, 2024, down from $5.5 million at December 31, 2023. Unrestricted cash was $2.4 million.
- Operating cash flow was negative $10.2 million, primarily reflecting increases in accounts receivable of $6.8 million, inventory of $1.7 million, and reductions in accounts payable of $4.5 million.
- Capital expenditures were $1.6 million, compared with $0.7 million in Q1 2023.
- Net cash provided by financing activities was $9.5 million, including approximately $10.2 million of net long-term borrowings and $0.6 million of shareholder distributions.
- Revolving credit borrowings were $23.3 million, with $41.7 million available under the $65 million HSBC facility. The facility bears interest at SOFR plus 1.75% and expires May 31, 2026.
- The mortgage balance was approximately $10.6 million, at a fixed interest rate of 3.8%, with maturity on December 1, 2031.
- The company was in compliance with its revolving credit covenants at March 31, 2024. Long-term debt to equity increased to 33.8% from 23.9% at year-end 2023.
- Working capital increased to $76.6 million from $66.0 million, and the current ratio improved to 4.51 from 3.54.
Management believes operating cash flow and available revolving credit capacity will be sufficient to fund operations for the next twelve months under current conditions.
Material Changes Versus the Prior Comparable Period
- Gross margin improved substantially due primarily to manufacturing and distribution productivity improvements and lower inbound freight costs.
- SG&A increased 5%, mainly because of higher personnel-related expenses.
- Net interest expense declined $0.5 million to $0.4 million, primarily because of lower average revolving debt during the quarter.
- Operating cash flow changed from $7.7 million provided in Q1 2023 to $10.2 million used in Q1 2024, driven by working-capital investment and lower operating liabilities.
- Revolving debt increased approximately $10.1 million from December 31, 2023, while cash declined.
- Operating lease right-of-use assets increased to $5.5 million from $2.0 million, including $3.8 million of non-cash lease additions during the quarter.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
The filing does not provide specific revenue, earnings, or cash-flow guidance. Management emphasizes seasonal variability and expects stronger sales and profits in the second and third quarters.
- Key cited risks include inflation, interest rates, global economic conditions, geopolitical conflicts, supply-chain disruptions, labor costs, currency fluctuations, inventory management, competition, online sales trends, acquisitions, and tariffs or other trade-policy changes.
- Disclosure controls and procedures were not effective as of March 31, 2024 because of an identified material weakness in information-technology general controls related to change management and logical controls.
- Remediation efforts include database change-management and auditing software and new management review procedures. Management expects remediation to be completed by December 31, 2024, subject to effective operation and testing of the controls.
- The company reports no pending material legal proceedings.
- A $0.75 million contingent payment related to the Safety Made acquisition is held in restricted cash and recorded as a current liability.
- The company sold the Camillus Cutlery and Cuda businesses for $19.8 million in November 2023; $1.5 million remains subject to a 12-month holdback primarily for indemnification claims.
Investor Verification Priorities
- Verify cash conversion: Determine whether the sharp Q1 operating cash outflow, especially receivables and inventory growth, reverses in subsequent quarters.
- Verify debt trajectory: Monitor revolving borrowings, interest costs, covenant compliance, and remaining liquidity under the $65 million facility.
- Verify margin sustainability: Assess whether productivity improvements and lower freight costs offset higher personnel and other SG&A expenses.
- Verify post-divestiture growth: Track comparable sales excluding Camillus and Cuda, particularly in Canada and the United States.
- Verify internal-control remediation: Confirm that the IT control material weakness is remediated and independently tested by year-end 2024.
- Verify contingencies and working capital: Review the Safety Made contingent liability, customer rebate accruals, inventory turnover, and accounts-receivable aging.